A deep dive into the relationship between antibiotics and fungal overgrowth reveals that while traditional thinking suggests a connection, emerging research indicates they may not always coexist. With extensive experience treating patients, one expert highlights the safety of rifaximin and the rarity of adverse reactions. The discussion emphasizes the importance of understanding bacterial overgrowth and considering antifungal treatments only when symptoms persist.
